Education
About Us
Working with TipRanks
Follow Us
Karah Herdman Parschauer Insider Profile
11 Followers
Karah Herdman Parschauer, EVP & CLO at Ultragenyx Pharmaceutical, holds 75.29K shares in Ultragenyx Pharmaceutical (Ticker: RARE), holds 37.71K shares in Evolus (Ticker: EOLS), holds ― shares in Arcturus Therapeutics (Ticker: ARCT).
Karah Herdman Parschauer Ultragenyx Pharmaceutical (RARE)EVP & CLO
Ultragenyx Pharmaceutical (RARE)
EVP & CLO
Ranked #4,832 out of 100,956 Corporate Insiders
Profitable Transactions
14 out of 15 Profitable Transactions
Average Return
+20.70%
Average return per transaction
Time Frame
Compare to
Insider Holdings
A breakdown of Karah Herdman Parschauer's holdings
Insider Roles
Roles that Karah Herdman Parschauer holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Sep 09, 2021 - Sep 09, 2022
Return:+51.30%
The most profitable trade made by Karah Herdman Parschauer
Karah Herdman Parschauer's Trading History
Ultragenyx Pharmaceutical
Mar 04, 2025
EVP & CLO
Uninformative Buy
―
$2.91M
Evolus
Feb 09, 2024
Director
Uninformative Buy
―
$512.06K
Arcturus Therapeutics
―
Director
―
―
Tenaya Therapeutics
―
Director
―
―
Anebulo Pharmaceuticals
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Karah Herdman Parschauer's performance on stock
You May Also Like
Karah Herdman Parschauer insider profile FAQ
What is the percentage of profitable transactions made by Karah Herdman Parschauer?
The percentage of profitable transactions made by Karah Herdman Parschauer is 93%.
What is the average return per transaction made by Karah Herdman Parschauer?
The average return per transaction made by Karah Herdman Parschauer is 20.70%.
What stocks does Karah Herdman Parschauer hold?
Karah Herdman Parschauer holds: RARE, EOLS, ARCT, TNYA, ANEB stocks.
What was Karah Herdman Parschauer’s latest transaction?
Karah Herdman Parschauer latest transaction was an Uninformative Buy of ―.
What was Karah Herdman Parschauer's most profitable transaction?
Karah Herdman Parschauer’s most profitable transaction was an Informative Sell of RARE stock on September 9, 2021. The return on the trade was 51.30%.
What is Karah Herdman Parschauer's role in Ultragenyx Pharmaceutical?
Karah Herdman Parschauer's role in Ultragenyx Pharmaceutical is EVP & CLO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.